Cat. No. 1374
Chemical Name: 6-Chloro-2,3-dihydro-5-methyl-N-5-q
Biological ActivityPotent 5-HT2B/2C receptor antagonist (pKi values are 8.3, 7.66 and 6.77 for 5-HT2B, 5-HT2C and 5-HT2A respectively). Increases wakefulness and motor activity in rats. Orally active.
Licensing InformationSold for research purposes under agreement from GlaxoSmithKline
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Kantor et al (2004) Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505. Br.J.Pharmacol. 142 1332. PMID: 15265808.
Reavill et al (1999) Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. Br.J.Pharmacol. 126 572. PMID: 10188965.
Kennett et al (1998) Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated. Neuropharmacology 37 1603. PMID: 9886683.
If you know of a relevant reference for SB 215505 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses SB 215505 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: SB 215505, supplier, Serotonin, 5-HT, 5-HT2C, 5-HT2B, antagonists, SB215505, potent, Tocris Bioscience, 5-HT2B Receptor Antagonist products